SCHEMBL20733016

SCHEMBL20733016

COC(=O)c1ccc(-c2cncc3ncc(N4CC(C(=O)N(C)C)C4)cc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MELK Q14680 1/20 0.42
CCNC P24863 8/20 0.40
CDK8 P49336 8/20 0.40
GPR119 Q8TDV5 1/20 0.38
SGK1 O00141 1/20 0.36
CAMKK2 Q96RR4 1/20 0.36
HPGD P15428 1/20 0.36
SLC2A1 P11166 1/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
MTOR P42345 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.35
EGFR P00533 1/20 0.35
SOS1 Q07889 1/20 0.34
PDE10A Q9Y233 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.34
DYRK1A Q13627 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20733019 0.89 CCNC (0.40) MELKCCNCCDK8GPR119CYP1A2
SCHEMBL22113717 0.86 CCNC (0.37) MELKCCNCCDK8GPR119HPGD
SCHEMBL20732975 0.85 CHEK1 (0.42) CCNCCDK8GPR119
SCHEMBL20733015 0.74 SGK1 (0.46) SGK1CAMKK2HPGDSLC2A1PIK3CD
SCHEMBL20733018 0.74 SGK1 (0.44) SGK1CAMKK2HPGDSLC2A1EGFR
SCHEMBL20733083 0.71 HPGD (0.59) CCNCCDK8HPGD
SCHEMBL20732892 0.67 CCNC (0.49) CCNCCDK8DYRK1A
SCHEMBL20732965 0.63 CCNC (0.54) CCNCCDK8
SCHEMBL10138348 0.62 SLC22A12 (0.51) CCNCCDK8SGK1CAMKK2SLC2A1
SCHEMBL14562446 0.61 ATM (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3666770-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS Joint Stock Company "Biocad" (RU) 2020-06-17 EP disclosed
WO-2019031990-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS ЗАКРЫТОЕ АКЦИОНЕРНОЕ ОБЩЕСТВО "БИОКАД" 2019-02-14 WO disclosed